Diagnostic Accuracy of Teledermatology in Patch Test Interpretation

NCT ID: NCT06213545

Last Updated: 2024-11-27

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

108 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-04-03

Study Completion Date

2024-11-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to learn about accuracy of teledermatology in patch test interpretation in patch test\'s patients population. The main question\[s\] it aims to answer are:

* Accuracy of teledermatology in patch test interpretation by dermatologist
* Accuracy of teledermatology in patch test interpretation by Residency
* Accuracy of teledermatology in patch test interpretation by Scitentist
* The factors influencing the interpretation of remote dermatologic patch test results from photographs of patients.

Participants will

* do patch test in Siriraj hospital and come to follow up at 48 hr and 72 hr for interpretation of patch test
* take a photo at home and sent the photo to contact clinic via online application or email on the day of 48 hr, 72 hr and 7 days following the interpretation of patch test

Researchers will compare in-clinic group and telephoto group to see if the accuracy of patch test interpretation is more or less.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Teledermatology

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SINGLE_GROUP

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

In-Clinic interpretation

After doing patch test, patient come to Siriraj hospital to interpret the results at 48 hr and 72 hr.

Group Type EXPERIMENTAL

In-clinic interpretation

Intervention Type DIAGNOSTIC_TEST

Reading patch test result at clinic

Photo interpretation

Intervention Type DIAGNOSTIC_TEST

Reading patch test result by sending photo to clinic

Photo interpretation

After doing patch test, patient take a photo to Siriraj hospital by LINE application to interpret the results at 48 hr, 72 hr and 7 days

Group Type EXPERIMENTAL

In-clinic interpretation

Intervention Type DIAGNOSTIC_TEST

Reading patch test result at clinic

Photo interpretation

Intervention Type DIAGNOSTIC_TEST

Reading patch test result by sending photo to clinic

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

In-clinic interpretation

Reading patch test result at clinic

Intervention Type DIAGNOSTIC_TEST

Photo interpretation

Reading patch test result by sending photo to clinic

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants in the study must be 18 years of age or older.
* Participants in the study must have undergone patch testing for contact allergies.
* Participants in the study should be able to take photos of test results on their back and/or arms using a mobile phone or personal camera, and send them to the researcher through the Line application and/or email within 48 hours, 96 hours, and on the 7th day.
* Participants in the study should be able to read and comprehend the questionnaire in Thai and respond to the questionnaire independently.
* Participants in the study must have at least one positive result in the patch testing.
* Participants in the study must provide consent to participate in the study by signing the informed consent document.

Exclusion Criteria

* Participants in the study who are unable to attend follow-up appointments for result assessments.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mahidol University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Silada Kanokrungsee

Department of Dermatology, Siriraj hospital

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Faculty of medicine, Siriraj hospital, Mahidol university

Bangkoknoi, Bangkok, Thailand

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Thailand

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

COA 694/2023

Identifier Type: -

Identifier Source: org_study_id